Round 2 at JASN

Nephrology beyond JASN

T hiazolidones are peroxisome proliferator-activated receptor (PPAR ) agonists that enhance insulin sensitivity and are increasingly used as oral antidiabetic agents. The two currently available agents are pioglitazone and rosiglitazone. Their use has dramatically increased recently and this year the results of major outcome trials are expected. Of interest to nephrologists, the thiazolidinedio...

NLSY97 Round 2 Data

The round 2 NLSY97 main file data are now available to interested researchers. The National Longitudinal Survey of Youth 1997 cohort includes 8,984 respondents aged 12 to 16 as of December 31, 1996. Of these, 8,386 sample members (93.3 percent) were interviewed in round 2. Surveyed respondents included 6,279 members (93.0 percent) of the cross-sectional sample and 2,107 members (94.2 percent) o...

The CORAL Trial, Round 2.

R enal artery stenosis (RAS) occurs in up to 5% of people with hypertension and is associated with ischemic nephropathy and other complications. It has been hypothesized that RAS is a potentially reversible cause of hypertension and these other sequelae, and the practice of renal artery stenting has grown to meet this perceived need. However, data from randomized controlled trials is somewhat e...

On 2-Round Se ure Multiparty Computation

Linear Approximations for 2-round Trivium

Trivium, designed by De Cannière and Preneel, is one of the focus ciphers of Phase II for the eSTREAM project. In this paper, we model the initialization part of Trivium as an 8-round function where each round consists of 144 Trivium clocks, and analyze the security margin in terms of number of rounds. This is an open question. Nevertheless, we give some partial answers. As one example, we appl...